| ［1］ |
Marks DH, Piantadosi AL, Patil SU, et al. Successful use of dupilumab for recalcitrant atopic dermatitis in an HIV patient［J］. Dermatitis, 2019,30（4）:276⁃277. doi: 10.1097/DER.0000000000 000501.
|
| ［2］ |
Olbricht N, Kromer C, Forkel S, et al. Effective treatment of atopic dermatitis with dupilumab in an HIV⁃positive patient［J］. J Dtsch Dermatol Ges, 2020,18（12）:1488⁃1490. doi: 10.1111/ddg.14244.
|
| ［3］ |
中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南（2020版）［J］. 中华皮肤科杂志, 2020,53（2）:81⁃88. doi: 10.35541/cjd.20191000.
|
| ［4］ |
Jianu C, Itu⁃Mureşan C, Drugan C, et al. Evaluation of several serum interleukins as markers for treatment effectiveness in naive HIV infected patients: a pilot study［J/OL］. PLoS One, 2021,16（11）:e0260007. doi: 10.1371/journal.pone.0260007.
|
| ［5］ |
中华医学会皮肤性病学分会特应性皮炎研究中心, 中华医学会皮肤性病学分会儿童学组. 度普利尤单抗治疗特应性皮炎专家共识［J］. 中华皮肤科杂志, 2022,55（6）:465⁃470. doi: 10. 35541/cjd.20210885.
|
